18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

NCT03181867 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

360

Enrollment

NIH

Sponsor class

Conditions

Prostate Neoplasms
Prostatic Cancer
Prostate Cancer
Cancer Of Prostate
Metastatic Prostate Cancer

Interventions

DRUG: 18F-DCFPyL
DRUG: 18F-FDG
DRUG: PSMA-11

Sponsor

National Cancer Institute (NCI)